Answer
Breastfeeding is not recommended during treatment with IVEMEND (fosaprepitant dimeglumine), because it is not known whether aprepitant is excreted in human milk.
Sources for this answer
- IVEMEND 150 mg powder for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 16Document updated
Sources checked